DANIEL HANONO: Open Payments
NPI 1679708242 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,774 in 83 payments from 12 companies in 2025. Trend: 2023 $2,174 · 2024 $2,748 · 2025 $1,774
Food & beverage: $1,774
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $432 |
| Forte Bio-Pharma LLC | 11 | $413 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 31 | $309 |
| Globus Medical, Inc. | 1 | $119 |
| Collegium Pharmaceutical, Inc. | 5 | $113 |
| Boston Scientific Corporation | 3 | $101 |
| PFIZER INC. | 4 | $94 |
| Valinor Pharma, LLC | 3 | $70 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Tonix Medicines, Inc. | 1 | $34 |
Products named: PROLATE, RELISTOR, UBRELVY, QULIPTA, Senza, XTAMPZA, WaveWriter Alpha Prime 16, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
